CB-5083 | m-entrepreneurship.com

Product Name :
CB-5083

Search keywords :
CB-5083

drugId :
null

Target Vo:
Transitional endoplasmic reticulum ATPase

Target Vo Short Name :
VCP

Moa_Name:
Transitional endoplasmic reticulum ATPase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cleave Biosciences Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Multiple Myeloma

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT1/2/3 Antibody (YA633)
Ku70 Antibody (YA319)
Caspase-1 p20 Antibody: Caspase-1 p20 Antibody is an unconjugated, approximately 20/46 kDa, rabbit-derived, anti-Caspase-1 p20 polyclonal antibody. Caspase-1 p20 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts